MEDICAL RECOMMENDATIONS

Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (≥35 weeks gestational age)

Canadian Paediatric SocietyPediatrics2025Official publication

ASEM documentary overview

Official Canadian Paediatric Society document (2025) on “Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (≥35 weeks gestational age)”. Hyperbilirubinemia is a common condition and is usually benign in term and late preterm newborns. Developing a standardized approach for all newborns to prevent, identify, and manage those with clinically significant hyperbilirubinemia will minimize the potential risks of long-term neurological sequelae from acute bilirubin encephalopathy and kernicterus. This statement provides recommendations on universal screening.

This overview helps you identify the document. Always consult the current official publication for clinical recommendations.

Official document